PharmaShots | Incisive News in 3 Shots

Subscribe Now

HER2-Overexpressing

Samsung Bioepis Launches Ontruzant (trastuzumab- biosimilar) for Early and Metastatic HER2-Overexpressing Breast Cancer in Brazil

Samsung Bioepis Launches Ontruzant (trastuzumab- biosimilar) for Early and Metastatic HER2-Overexpressing Breast Cancer in Brazil

August 11, 2020

Celltrion and Teva's Herzuma (trastuzumab-pkrb- Herceptin biosimilar) Receives FDA's Approval for HER2-Overexpressing Breast Cancer

Celltrion and Teva's Herzuma (trastuzumab-pkrb- Herceptin biosimilar) Receives FDA's Approval for HER2-Overexpressing Breast Cance...

December 14, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us